Doxorubicin resistance in breast cancer is mediated via the activation of FABP5/PPARγ and CaMKII signaling pathway by Nan-Nan Chen, Xin-Di Ma, Zhuang Miao, Xiang-Mei Zhang, Bo-Ye Han, Ahmed Ali Almaamari, Jia-Min Huang, Xue-Yan Chen, Yun-Jiang Liu, Su-Wen Su

Get full text